You are viewing: Italy Endoscopic Submucosal Dissection/ESD Market analysis

The Italy Endoscopic Submucosal Dissection/ESD Market was valued at $9.6 Million in 2025 and projected to reach to $14.5 Million by 2030, representing a compound annual growth rate of 8.5%. Italy's ESD market demonstrates steady momentum as healthcare institutions modernize their endoscopic capabilities and clinicians gain proficiency in advanced techniques.

Italy Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This growth trajectory reflects Italy's increasing adoption of minimally invasive gastrointestinal procedures and rising healthcare investment in advanced endoscopic technologies.
  • Italy's healthcare system continues to prioritize precision oncology and early cancer detection, driving demand for ESD as a preferred treatment modality for early-stage gastrointestinal malignancies. The Italian market benefits from a well-established medical device infrastructure and strong clinical expertise in gastroenterology.
  • Italy's aging population and prevalence of gastric and esophageal cancers create sustained demand for ESD procedures.
  • Healthcare providers across Italy are increasingly recognizing ESD's advantages over traditional surgical resection, including reduced morbidity, shorter hospital stays, and improved patient outcomes, which collectively support market expansion through 2030..

Key Market Statistics

  • CAGR (2025-2030) 8.5% CAGR
  • Market Size, 2025 ~USD 9.6 Million
  • Forecast, 2030 ~USD 14.5 Million
  • Country Italy

Italy Endoscopic Submucosal Dissection/ESD Market Overview

Market Growth Trajectory :

Italy's ESD market is projected to grow from $9.6 million in 2025 to $14.5 million by 2030, representing a robust 8.5% CAGR that aligns closely with global expansion rates.

Minimally Invasive Adoption :

Italian healthcare providers are increasingly embracing endoscopic submucosal dissection as a preferred alternative to traditional surgical interventions, driven by patient demand for reduced recovery times and lower morbidity rates.

Healthcare Investment Focus :

Italy's national healthcare system continues to prioritize funding for advanced endoscopic technologies, supporting infrastructure development and training programs across major medical centers and regional hospitals.

Gastrointestinal Disease Prevalence :

Rising incidence of early-stage gastrointestinal cancers and precancerous lesions in Italy is creating sustained demand for ESD procedures, particularly in specialized gastroenterology departments.

Italy Endoscopic Submucosal Dissection/ESD Market Dynamics

  • The convergence of aging demographics, increased cancer screening initiatives, and European healthcare standards compliance is driving procedural volume growth across Italian hospitals.
  • Investment in training programs and equipment acquisition by major medical centers positions the market for sustained expansion through 2030. The Italian market benefits from strong reimbursement frameworks within the national healthcare system and growing patient awareness of minimally invasive treatment options.
  • Regional disparities between northern and southern Italy present opportunities for market penetration in underserved areas.
  • Continued collaboration with European medical societies and adoption of international best practices will further accelerate ESD adoption among Italian gastroenterologists..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Italy's ESD market is projected to grow from $9.6 million in 2025 to $14.5 million in 2030, representing an 8.5% compound annual growth rate.
    • Italy's aging demographic and high prevalence of early-stage gastrointestinal cancers drive sustained clinical demand for ESD procedures.
    • Italy's robust healthcare infrastructure and gastroenterology expertise position the country as a key adopter of advanced endoscopic technologies.
    • Minimally invasive procedure preferences and improved reimbursement policies in Italy support accelerated ESD market penetration through 2030.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Italy Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS2.913.13.43.663.974.314.675.078.3
    HOSPITALS10.8511.612.7813.815.0616.4217.8619.458.8
    OTHER END USERS0.390.410.450.480.510.550.590.637
    SPECIALTY CLINICS3.673.94.274.584.965.375.86.278
    TOTAL17.8219.0220.8922.5124.5126.6528.9131.428.5

    Target Audience

    • Medical Device Manufacturers : Manufacturers of endoscopic equipment and ESD-specific instruments need Italy-specific market data to develop localized go-to-market strategies and identify distribution partnerships within Italian healthcare networks.
    • Hospital Administrators & Procurement Teams : Italian hospital decision-makers require market insights to justify capital investments in ESD technology, benchmark against peer institutions, and align procurement with national healthcare priorities.
    • Gastroenterology Specialists : Italian gastroenterologists and endoscopists seek market intelligence on emerging techniques, training opportunities, and equipment innovations to enhance their clinical capabilities and patient outcomes.
    • Healthcare Investors & Consultants : Investment firms and management consultants analyzing the Italian healthcare sector need granular market data on ESD growth drivers, reimbursement trends, and competitive dynamics for investment thesis development.
    • Healthcare Policy Makers : Italian health ministry officials and regional healthcare administrators use market research to inform resource allocation decisions, training program development, and healthcare technology adoption policies.

    Key Companies in the Italy Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Localized Market Intelligence : Gain Italy-specific insights on market size, growth rates, and competitive dynamics that inform strategic planning for market entry or expansion within the Italian healthcare sector.
    • Healthcare System Understanding : Understand Italy's reimbursement landscape, regulatory requirements, and healthcare procurement processes essential for successfully positioning ESD products and services to Italian providers.
    • Regional Growth Opportunities : Identify high-potential regions within Italy where ESD adoption is accelerating and where investment in training, equipment, and infrastructure presents commercial opportunities.
    • Competitive Positioning : Benchmark your offerings against Italian market trends and competitor strategies to optimize pricing, distribution, and marketing approaches for the Italian healthcare market.
    • Investment Decision Support : Make data-driven investment decisions regarding facility expansion, technology acquisition, or partnership development in Italy's growing minimally invasive endoscopy sector.

    Frequently asked questions

    What is the current market size of ESD in Italy?

    Italy's ESD market was valued at $9.6 million in 2025 and is expected to reach $14.5 million by 2030.

    What is the projected growth rate for Italy's ESD market?

    Italy's ESD market is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2030.

    What factors are driving ESD adoption in Italy?

    Key drivers include Italy's aging population, high prevalence of early-stage gastrointestinal cancers, strong gastroenterology expertise, and healthcare system preference for minimally invasive procedures.

    How does Italy's ESD market compare to other European countries?

    Italy represents a significant European market for ESD, supported by advanced healthcare infrastructure, established clinical protocols, and strong reimbursement frameworks that facilitate procedure adoption.

    What are the main clinical applications of ESD in Italy?

    In Italy, ESD is primarily used for treatment of early-stage gastric and esophageal cancers, Barrett's esophagus, and other early gastrointestinal malignancies where tissue preservation is clinically advantageous.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status